# Emergent BioSolutions Inc.: Form 8-K, filed May 25, 2017

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2017-05-25
- Accepted by EDGAR: May 25, 2017, 16:23 ET
- Period: 2017-05-25
- Accession: 0001367644-17-000024
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764417000024/form8k5252017.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764417000024/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764417000024/form8k5252017.htm

Filed May 25, 2017.
Source: SEC EDGAR, the filing index for accession 0001367644-17-000024. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
